Evidence map›Paper›PMID 12805417›Full record

ArticleJournal of virology2003

Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes.

Xiuqing Wang, Martin Messerle, Ramil Sapinoro, Kathlyn Santos, Peter K Hocknell, Xia Jin, Stephen Dewhurst

Abstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. mNature immunology · 2019
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Xiuqing WangDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York 14642, USA.
Martin Messerle
Ramil Sapinoro
Kathlyn Santos
Peter K Hocknell
Xia Jin
Stephen Dewhurst
Martin Luther University Halle-Wittenberg · DEUniversity of Rochester Medical Center · US

Funding

HSV Amplicon Vectors for HIV Vaccine DevelopmentR21AI049804 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI DANDEKAR, SATYA · 2001 to 2002
$430k
CYTOMEGALOVIRUS VECTORS FOR HIV VACCINE DEVELOPMENTR21AI046259 · NIAID · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN · 1999 to 2000
$239k
NIAID NIH HHS R21 AI46259NIAID NIH HHS R21 AI49804PHS HHS F31 54 330
6 · The paper itself

Abstract

Dendritic cells (DC) are potent antigen-presenting cells that play a crucial role in antigen-specific immune responses. Thus, the targeting of exogenous antigens to DC has become a popular approach for cancer immunotherapy and vaccine development. In this report, we studied the interplay between murine cytomegalovirus (MCMV) and human monocyte-derived DC. The results showed that an enhanced green fluorescent protein (EGFP)-encoding, replication-competent MCMV vector underwent abortive infection in human DC; this was accompanied by the efficient expression of EGFP. Infection of human DC by this vector resulted in a modest increase in the expression of cell surface proteins associated with DC maturation and has no significant effect on the immunostimulatory function of the cells, as reflected by their ability to support T-cell proliferation in a mixed-lymphocyte reaction. Finally, an MCMV vector encoding the human immunodeficiency virus type 1 (HIV-1) gp120 envelope glycoprotein was constructed and used to infect cultured human DC. The infected DC were shown to be capable of stimulating the expansion of autologous, gp120-specific, class I-restricted T lymphocytes from an HIV-1-negative donor, as determined by tetramer staining and enzyme-linked immunospot analysis. Taken together, these results suggest that MCMV may have potential utility as a vector for human vaccine development.

Indexed as

Genetic VectorsBlotting, WesternDendritic CellsGreen Fluorescent ProteinsHIV Envelope Protein gp120HumansImmunophenotypingLuminescent ProteinsMicroscopy, ElectronMuromegalovirusTransduction, GeneticVirus ReplicationGreen Fluorescent ProteinsHIV Envelope Protein gp120Luminescent Proteins

Identifiers

PMID12805417
PMCPMC164805
OpenAlexW1972555452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.